Clinical Trial Update: Combination Drug Therapy for Patients With Hepatitis C [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update on a combination drug therapy for chronic hepatitis C with liver fibrosis, with the study status shown as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Liver Fibrosis

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Chronic Hepatitis C, Fibrosis | Phase 3 | Status: COMPLETED